Aequim Alternative Investments’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-43,000
| Closed | -$3.76M | – | 102 |
|
|
2024
Q1 | $3.76M | Hold |
43,000
| – | – | 0.14% | 74 |
|
|
2023
Q4 | $4.15M | Hold |
43,000
| – | – | 0.17% | 66 |
|
|
2023
Q3 | $3.8M | Hold |
43,000
| – | – | 0.14% | 71 |
|
|
2023
Q2 | $3.73M | Hold |
43,000
| – | – | 0.14% | 74 |
|
|
2023
Q1 | $4.18M | Buy |
43,000
+22,900
| +114% | +$2.23M | 0.13% | 80 |
|
|
2022
Q4 | $2.08M | Buy |
20,100
+6,100
| +44% | +$631K | 0.06% | 105 |
|
|
2022
Q3 | $1.19M | Hold |
14,000
| – | – | 0.03% | 115 |
|
|
2022
Q2 | $1.16M | Hold |
14,000
| – | – | 0.04% | 116 |
|
|
2022
Q1 | $1.08M | Hold |
14,000
| – | – | 0.03% | 125 |
|
|
2021
Q4 | $1.24M | Hold |
14,000
| – | – | 0.04% | 101 |
|
|
2021
Q3 | $1.08M | Buy |
14,000
+2,800
| +25% | +$216K | 0.04% | 91 |
|
|
2021
Q2 | $935K | Hold |
11,200
| – | – | 0.04% | 93 |
|
|
2021
Q1 | $846K | Hold |
11,200
| – | – | 0.05% | 81 |
|
|
2020
Q4 | $982K | Hold |
11,200
| – | – | 0.07% | 71 |
|
|
2020
Q3 | $852K | Sell |
11,200
-32,800
| -75% | -$2.5M | 0.11% | 62 |
|
|
2020
Q2 | $5.43M | Hold |
44,000
| – | – | 0.82% | 23 |
|
|
2020
Q1 | $3.72M | Buy |
44,000
+22,000
| +100% | +$1.86M | 0.62% | 32 |
|
|
2019
Q4 | $1.86M | Hold |
22,000
| – | – | 0.35% | 43 |
|
|
2019
Q3 | $1.48M | Buy |
22,000
+11,000
| +100% | +$742K | 0.3% | 40 |
|
|
2019
Q2 | $942K | Buy |
+11,000
| New | +$942K | 0.27% | 37 |
|